LabCompass

Kathryn D. Fischer

Neuroscience · Indiana University

OpenAlex
Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorMitochondrial Function and PathologyGenetic Neurodegenerative DiseasesReceptor Mechanisms and Signaling

Publications

14

Citations

589

Est. group size

—

Recurring co-author estimate

Active years

13

Publishing since 2013

Research summary
AI-generated

Kathryn D. Fischer studies how the brain manages chemical signaling molecules, especially glutamate, and how disruptions relate to conditions like addiction, psychiatric disorders, and neurodegenerative diseases. Much of the work uses genetically engineered mice (for example, deleting a glutamate transporter called GLT-1 in neurons) to examine effects on brain chemistry, mitochondrial energy function, and behavior. Recent projects also explore models of Alzheimer's disease, Huntington's disease, and drug treatments for psychosis.

Glutamate signaling and homeostasis in the brainGenetic mouse models of neurological diseaseNeuropharmacology and behaviorMitochondrial function in neuronsAddiction and dopamine signaling

Publication activity has been steady over the last several years, averaging roughly one to two papers per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
172018: 2 publications182019: 1 publication192020: 2 publications20212022: 2 publications222023: 1 publication232024: 3 publications3242025: 1 publication2526
Recent publications
Publishes in
  • Neurochemistry International×2
  • Proceedings of IMPRS×2
  • Journal of Neuroscience×1
  • Neurochemical Research×1
  • Psychopharmacology×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile